Pure Biologics S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was PLN 16.96 million compared to PLN 12.02 million a year ago. Basic loss per share from continuing operations was PLN 5.39 compared to PLN 5.33 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.81 PLN | +0.64% | -3.46% | -38.21% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.21% | 6.42M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PUR Stock
- News Pure Biologics S.A.
- Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023